StonvexLoading…
StonvexStonvexStonvexCore line items from ARKO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.64B | $8.73B | $9.41B | $9.14B |
Operating Income | $102.30M | $94.03M | $118.01M | $167.01M |
Net Income | $22.74M | $20.84M | $34.37M | $71.75M |
EPS (Diluted) | $0.15 | $0.13 | $0.24 | $0.53 |
Total Assets | $3.53B | $3.62B | $3.65B | $3.26B |
Total Liabilities | $3.17B | $3.24B | $3.27B | $2.87B |
Cash & Equivalents | $305.00M | $261.76M | $218.12M | $298.53M |
Free Cash Flow OCF − CapEx | $65.30M | $107.94M | $24.93M | $110.66M |
Shares Outstanding | 110.86M | 115.77M | 116.17M | 120.07M |